Credit: CC0 Public Domain A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV—short for respiratory syncytial virus—vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023–24 respiratory disease season, the...
Tag: <span>RSV vaccine</span>
Post
CDC strengthens RSV vaccine advice for those over 75
by Robin Foster In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives. However, those a bit younger—ages 60 to 74—should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung...
Post
Many older adults want RSV vaccine, poll shows
by University of Michigan Many older adults want RSV vaccine, poll showsKey findings from the National Poll on Healthy Aging poll of adults age 60 to 80 about their awareness of, and interest in getting, the first vaccine against respiratory syncytial virus or RSV. Credit: University of MichiganThe first Americans over age 60 just started...
Post
How to increase acceptance of an RSV vaccine? Explain the FDA’s vaccine approval process
ANNENBERG PUBLIC POLICY CENTER OF THE UNIVERSITY OF PENNSYLVANIA IMAGE: FIGURE SHOWS THE PERCENTAGE OF INDIVIDUALS WHO WOULD RECOMMEND VACCINATION AGAINST RSV TO A PREGNANT FAMILY MEMBER OR FRIEND. SOURCE: ANNENBERG PUBLIC POLICY CENTER’S ASAPH SURVEY, MAY 30-JUNE 6, 2023. CREDIT: ANNENBERG PUBLIC POLICY CENTER PHILADELPHIA – A new study finds that people are more likely to...
Post
US approves second RSV vaccine
Transmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public Domain The US drug regulator approved a second vaccine against respiratory syncytial virus (RSV), its American developer Pfizer said Wednesday, a month after the authorization of the first shot against the pathogen, a leading cause of lung infections. The announcement comes only weeks...
Post
A flurry of RSV vaccine research may result in a protective immunization in the not-too-distant future
by Delthia Ricks, Medical Xpress Plasmablasts at W0 and W1 post-vaccination. (A) Representative plasmablast plots are shown for a single participant vaccinated with DS-Cav1 (pre-F, N = 30) or MEDI7510 (post-F, N = 30) at week 0 (W0) and week 1 (W1). Cells were gated on live, singlet, lymphocytes then CD19+ prior to gating CD38+ CD20- plasmablasts. (B)...
Post
Why Pfizer’s RSV vaccine success is a big deal, decades in the making
BETH MOLE – 11/2/2022, 1:27 PM Enlarge / An intensive care nurse cares for a patient suffering from respiratory syncytial virus (RSV), who is being ventilated in the children’s intensive care unit of the Olga Hospital of the Stuttgart Clinic in Germany. Getty | picture alliance As an unusually large and early seasonal surge of RSV cases...